Active electroceutical treatment of Pseudomonas aeruginosa infected murine wounds
PLOS One · 2025
DOI: 10.1371/journal.pone.0331785 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Colin R Mack und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, United States of America. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Wound Infection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. Department of Defense.
Abstract (Originalsprache)
Chronic, infected dermal wounds have a high burden of cost and remain a persistent hurdle within healthcare. Electroceutical dressings that deliver antimicrobial agents directly to the wound site have emerged as an alternative solution to current standards of care. Here, through a systematic evaluation in an infected murine wound model we report on an actively powered electroceutical dressing that generates hypochlorous acid in situ as an antimicrobial agent to clear infection. In a significant new discovery, we also report that the treatment of these infected wounds with the actively powered electroceutical promotes the closure of wounds better than other test conditions. In a 10-day murine study, mice were wounded, and the dermal injury was infected with Pseudomonas aeruginosa . Four treatment plans were administered to these wounds: no treatment, a commercially available electroceutical dressing, and our electroceutical dressing both powered and unpowered. The mice were subsequently sacrificed 8 days post infection. The powered electroceutical dressing demonstrated significantly reduced bacterial burden compared to untreated wounds. The powered electroceutical dressing also showed the highest wound closure with nearly 60% wound area reduction and approximately 36% percent re-epithelization of the wound bed in contrast to the no-treatment case. When compared against the other treatments, the powered electroceutical dressing demonstrated an improved capability in promoting wound area reduction while lowering infection burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, United States of America.
- Department of Pathology, The Ohio State University, Columbus, Ohio, United States of America.
- Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.
- Department of Microbiology, The Ohio State University, Columbus, Ohio, United States of America.
- Department of Mechanical and Aerospace Engineering, The Ohio State University, Columbus, Ohio, United States of America.
- Department of Orthopedics, The Ohio State University, Columbus, Ohio, United States of America.
ORCID-Profile: Shaurya Prakash
Förderung
- NCI NIH HHS
- U.S. Department of Defense
Zitieren
APA
Mack, C. R., Wilgus, T. A., Dellos-Nolan, S., DiCesare, T., Bentley, D., Daniel, F. J., Subramaniam, V. V., Mahajan, S., Stoodley, P., Wozniak, D. J., & Prakash, S. (2025). Active electroceutical treatment of Pseudomonas aeruginosa infected murine wounds. PLOS One. https://doi.org/10.1371/journal.pone.0331785
Vancouver
Mack CR, Wilgus TA, Dellos-Nolan S, DiCesare T, Bentley D, Daniel FJ, et al. Active electroceutical treatment of Pseudomonas aeruginosa infected murine wounds. PLOS One. 2025. doi:10.1371/journal.pone.0331785
BibTeX
@article{Mack2025,
author = {Mack, Colin R and Wilgus, Traci A and Dellos-Nolan, Sheri and DiCesare, Tony and Bentley, Daria and Daniel, Fraser J and Subramaniam, Vish V and Mahajan, Sahil and Stoodley, Paul and Wozniak, Daniel J and Prakash, Shaurya},
title = {Active electroceutical treatment of Pseudomonas aeruginosa infected murine wounds},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331785}
}
EUVIMED